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Chronic kidney disease (CKD) is the most common metabolic disease of 
domesticated cats with most affected cats being geriatric (>12 years of 
age).  The prevalence of CKD in cats exceeds that observed in dogs and 
the frequency of the diagnosis of CKD in cats has increased in recent 
decades.  Typical histologic features include tubulointerstitial inflammation, 
tubular atrophy, and fibrosis with secondary glomerulosclerosis.  In 
contrast to people and dogs, primary glomerulopathies with marked 
proteinuria are relatively rare findings in cats.  Although a variety of 
primary renal diseases have been implicated, the disease is idiopathic in 
most cats.  Tubulointerstitial changes, including fibrosis, are present in the 
early stages of feline CKD and become more severe in advanced 
disease.  A variety of factors, including aging, ischemia, comorbid 
conditions, phosphorus overload, and routine vaccinations have been 
implicated as factors that could contribute to the initiation of this disease in 
affected cats.   Factors that are related to progression of established CKD, 
which occurs in some but not all cats, include dietary phosphorus intake, 
magnitude of proteinuria, and anemia. Renal fibrosis, a common histologic 
feature of aged feline kidneys, interferes with the normal relationship 
between peritubular capillaries and renal tubules.  Experimentally, renal 
ischemia results in morphologic changes similar to those observed in 
spontaneous CKD.  Renal hypoxia, perhaps episodic, may play a role in the 
initiation and progression of this disease. 
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Abstract 
 
Chronic kidney disease (CKD) is the most common metabolic disease of domesticated cats with 
most affected cats being geriatric (>12 years of age).  The prevalence of CKD in cats exceeds 
that observed in dogs and the frequency of the diagnosis of CKD in cats has increased in recent 
decades.  Typical histologic features include interstitial inflammation, tubular atrophy, and 
fibrosis with secondary glomerulosclerosis.  In contrast to people and dogs, primary 
glomerulopathies with marked proteinuria are remarkably rare findings in cats.  Although a 
variety of primary renal diseases have been implicated, the disease is idiopathic in most cats.  
Tubulointerstitial changes, including fibrosis, are present in the early stages of feline CKD and 
become more severe in advanced disease.  A variety of factors, including aging, ischemia, 
comorbid conditions, phosphorus overload, and routine vaccinations have been implicated as 
factors that could contribute to the initiation of this disease in affected cats.   Factors that are 
related to progression of established CKD, which occurs in some but not all cats, include dietary 
phosphorus intake, magnitude of proteinuria, and anemia. Renal fibrosis, a common histologic 
feature of aged feline kidneys, interferes with the normal relationship between peritubular 
capillaries and renal tubules.  Experimentally, renal ischemia results in morphologic changes 
similar to those observed in spontaneous CKD.  Renal hypoxia, perhaps episodic, may play a 
role in the initiation and progression of this disease. 
 
Keywords 
Aging; Cats; Chronic Kidney Diseases; Fibrosis; Proteinuria; Renal Insufficiency; Interstitial 
Inflammation 
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 Chronic kidney disease (CKD) is the most common metabolic disease of domesticated cats.  
Reflecting differences in patient populations such as age and diagnostic criteria, estimates of 
the overall prevalence of feline CKD have ranged from 1-3%
10,168
 to 50%.
141
  Although many cats 
with CKD would be expected to die of non-renal causes, in a necropsy study renal disease was 
the cause of death in 4% of cats dying at 1-5 years of age and in 17% of cats dying at 11 years of 
age or older.
93
 In a study of longevity in companion animals in the UK, mortality was attributed 
to renal disorders in 12.1% of cats with this diagnosis being the most frequently (13.6%) 
identified cause of mortality at or after 5 years of age in cats.
156
  In a Swedish study of cats that 
were insured up to 13 years of age, disorders of the kidneys or ureters were the most 
commonly identified cause of mortality, with an age-standardized mortality rate of 713 per 
10,000 cat-years at risk.
66
  Feline CKD is a frequent diagnosis in clinical practice, and the most 
common metabolic disease in cats presented to a veterinarian for evaluation.
135
 The prevalence 
in cats is higher than that observed in dogs,
163
 with a recent estimate of apparent prevalence of 
CKD of 0.21% in dogs.
157
  Interestingly, in another member of the felidae family (captive 
populations of cheetahs), CKD is also a common finding.
20,152,153
  
 Although there is limited data on the prevalence of CKD in cats, studies have identified two 
consistent trends in the prevalence of feline CKD. First, as in dogs,
10,163
 congenital disease 
causes a transient increase in prevalence of CKD in animals <3 years of age and the prevalence 
of CKD increases with advancing age from 5-6 years onward.  Estimates of the prevalence of 
CKD in geriatric cats have ranged from 35%
10,121
 to 81%.
141
 When data in dogs and cats were 
similarly obtained, the prevalence of CKD in geriatric cats exceeded that observed in geriatric 
dogs by 2-fold or more.
163
  A second trend is the increasing prevalence of the diagnosis of CKD 
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in cats during recent decades.  Data from the Purdue Veterinary Medical Database suggests 
that the overall prevalence of feline CKD in this database increased from 0.04% in the 1980’s to 
0.2% in 1990’s to 1% by the 2000’s.
134,168,171
 Whether this increase is a reflection of increased 
awareness with enhanced diagnostic acumen, an increase in the median age within cat 
populations,
22,66
  or a true increase in prevalence is unknown.   
 
Clinical findings  
The severity of CKD in cats varies and may be staged according to recommendations of the 
International Renal Interest Society (IRIS; Table 1).
71
 In general, the prevalence of CKD-
associated complications (i.e., hyperphosphatemia, secondary renal hyperparathyroidism, 
hypokalemia, anemia, proteinuria, systemic hypertension, metabolic acidosis, and uremia) rises 
with advancing stage,
71
 such that the treatment
71
  and the prognosis
26
 varies with IRIS CKD 
stage.  With few exceptions, these manifestations are common to all causes of CKD in cats, are 
similar to those observed in other species, and have been the subject of recent reviews.
10
 
162,168
   
 
Pathological Findings 
Although primary glomerular diseases, such as immune complex glomerulonephritis
86,154
 and 
amyloidosis,
8,25
 are described in cats and may result in chronic tubulointerstitial lesions (Figs. 1, 
2), the majority of geriatric cats with CKD do not have histologic evidence of primary glomerular 
disease.
50,133,146
  Instead, in the majority of cats with CKD, the primary lesions are within the 
tubulointerstitial compartment with only mild, presumed secondary, sclerotic lesions occurring 
within glomeruli.
50,146
  Grossly, kidneys from cats with CKD are decreased in size with surface 
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pitting (Fig. 3).  Histologically, renal lesions are multifocal to segmental (Fig. 4) and include 
interstitial mononuclear cell inflammation, tubular degeneration and atrophy, interstitial 
fibrosis, mineralization of Bowman’s capsule and tubular basement membranes, interstitial 
lipid, and glomerulosclerosis.
50,146
   
 While tubular atrophy, interstitial inflammation, and fibrosis are present in all cats with CKD, 
they are more severe in more advanced disease.
50,146
 The inflammatory infiltrate typically 
consists of lymphocytes, which may be the sole inflammatory cell type present in IRIS CKD stage 
1,
146
 or may be admixed with plasma cells and macrophages, and are typically present  within 
the interstitium surrounding atrophic tubules.  Atrophic cortical tubules often occur in clusters, 
are decreased in size, and exhibit basement membrane thickening and wrinkling (Fig. 5) or 
thinning (Fig. 6).  Interstitial lipid accompanied by granulomatous inflammation, is common in 
IRIS CKD stages 2-4, and may be secondary to tubular ischemia and rupture,
146
 with release of 
intraepithelial lipid (Fig. 6).  Interstitial fibrosis accompanies the interstitial inflammation and 
tubular atrophy, is correlated with the severity of the azotemia,
50
 and is most severe in cats 
with IRIS CKD stage 4.
146
     
 Within affected kidneys, glomeruli often are increased in size (glomerular hypertrophy), and 
may exhibit mild expansion of the mesangial matrix (glomerulosclerosis; Figs. 7, 8).
50
  In cats 
with more profound nephron loss, hyperperfusion of enlarged glomeruli
35
 may cause podocyte 
damage and loss, resulting in the lesion of focal segmental glomerulosclerosis.   Compared to 
dogs,
43,77,78
 secondary glomerulosclerosis in the remnant kidney model is comparatively mild in 
cats
76
 and in spontaneous feline CKD focal segmental glomerulosclerosis, when present, 
similarly affects relatively few glomeruli and only a small portion of the capillary tuft.
50
  Varying 
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proportions of glomeruli in cats with CKD are decreased in size and are globally sclerotic or 
obsolescent.  While global glomerulosclerosis appears to be a normal aging change in geriatric 
cats, it is also a pathologic change that increases significantly in severity in progressive stages of 
CKD.
146
  In cats with CKD, globally sclerotic glomeruli may exhibit thickening and wrinkling of 
the glomerular basement membrane, collapse of the capillary tuft, and fibrosis within the 
urinary space (Fig 9). These changes are more consistent with ischemic glomerular 
obsolescence rather than progression of focal segmental glomerulosclerosis.
99
  Shrunken 
globally sclerotic glomeruli may be difficult to discern within the fibrotic interstitium (Fig. 10).   
 
Pathogenesis of Feline CKD 
The traditional view of the course of CKD
27,41
 is that an initiation phase precedes a progression 
phase.   In this scenario, a primary renal disease (e.g., diabetic nephropathy, immune complex 
deposition) initiates the damage to the kidneys, resulting in nephron loss in early CKD.  
Eventually, enough nephrons are lost that other factors, intrinsic to the affected animal, 
produce self-perpetuating renal injury in what is termed inherent or intrinsic progression.  This 
scenario, with initiation and subsequent activation of progression factors, is presumed to be the 
situation in cats with CKD (Fig. 11).   
  
Chronic Primary Renal Diseases 
In other species, it is generally thought that a primary renal disease serves as the initiating 
factor for the CKD and this primary disease is often referred to as the “cause” of the CKD. A 
variety of primary renal diseases that can cause CKD have been identified in cats: 
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• Amyloidosis
25
 
• Juvenile renal dysplasia or glomerular disease
6,203
 
• Chronic feeding of unbalanced diets
63
 
• Lymphoma
61
 
• Polycystic kidney disease
13,136
 
• Bacterial pyelonephritis
61
  
• Nephro- and ureterolithiasis
125,126
 
• Chronic infection with feline immunodeficiency,
12,161
 feline leukemia
86
, or feline 
infectious peritonitis 
61
 virus 
• Immune complex glomerulonephritis
154,209
 
• Acute kidney injury (AKI) 
 
 With the exception of AKI, most of these known primary renal diseases affect only specific 
breeds of cats (e.g., amyloidosis, renal dysplasia, polycystic kidney disease), are believed to 
affect a very small number of animals (e.g., unbalanced diets, immune complex 
glomerulonephritis), or produce histologic changes (e.g., amyloidosis, lymphoma, polycystic 
kidney disease) that are inconsistent with the pathological changes of CKD
50,64,146
 that are 
usually observed in the kidneys of affected cats.  Some of these chronic renal diseases, such as 
bacterial infection and uroliths, might be expected to produce histologic changes consistent 
with typical observations in affected feline kidneys.  For example, bacterial urinary tract 
infections are relatively more common in cats with CKD
145
 and upper tract infection would be 
expected to produce tubulointerstitial changes. However, antibiotic treatment of cats with CKD 
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with a concomitant bacterial urinary tract infection does not impact survival
204
 and most cats 
with CKD have sterile urine.
145
   Ureteroliths and nephroliths are observed in some cats with 
CKD, but these typically are unilateral. Further, most cats with unilateral ureteroliths have a 
small contralateral kidney,
125
 suggesting that the CKD was pre-existing.
168
   
 Viral infections have been considered as possible initiating causes of CKD in cats.  In people, 
human immunodeficiency virus-associated nephropathy is predominantly a glomerular disease 
that is accompanied by less specific tubulointerstitial lesions.
58
   A similar virus occurring in cats, 
feline immunodeficiency virus (FIV), is associated with mild proteinuria,
12
  and both glomerular 
amyloidosis and presumed immune complex glomerulonephritis have been described in FIV-
positive cats.
161
  In addition to these glomerular lesions, nonspecific tubulointerstitial changes 
were also noted in FIV-positive cats.  However, in comparing FIV-infected and -noninfected cats 
in the clinical setting, the incidence of azotemic renal disease was similar in both groups, 
suggesting that FIV may not be a significant cause of CKD in cats.
12
     
 A recent report described the isolation of a paramyxo irus, feline morbillivirus, from 56 
(12%) of 457 feral cats in China and suggested an association between tubulointerstitial renal 
disease and viral infection.
208
  Necropsies performed on 12 virus-positive and 15 virus-negative 
feral cats revealed nonspecific tubulointerstitial nephritis in 7 and 2 cats, respectively.  
Distinguishing these changes from relatively common spontaneous CKD renal lesions is difficult, 
and further investigation into this potential association between paramyxovirus infection and 
tubulointerstitial nephritis is warranted. 
 In people
3,120,185
 and dogs,
57,118,177,194
 a variety of primary and secondary glomerulopathies 
including immune complex glomerulonephritis are initiating diseases in many, perhaps most, 
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cases of CKD.  The common primary chronic renal diseases in people (i.e., hypertension, 
diabetes, immune complex glomerulonephritis)
214
 involve the glomerulus as a primary target 
with significant proteinuria as a hallmark.  In cats, while proteinuria is an important predictor of 
progression
51
 and mortality
188
 as in other species, marked proteinuria and primary glomerular 
disease are uncommon.  Further, diabetes does not lead to significant renal structural or 
functional changes in cats
216
 and, in contrast to people, glomerular lesions secondary to feline 
hypertension are comparatively mild.
50
   
 While it is widely accepted that the presence of CKD enhances the susceptibility of the 
kidney to toxic or ischemic insults, clinical observations support the notion that an AKI can 
initiate CKD in people
53
 and dogs.
9
  Tubulointerstitial changes similar to those observed in feline 
CKD, particularly interstitial inflammation and fibrosis, occur during the recovery phase of an 
AKI,
112
 and have been observed in cats following experimental renal ischemia.
175
  After an AKI, 
these repair mechanisms may become maladaptive, leading to CKD.
72
  The importance of AKI as 
an initiator of spontaneous CKD in cats has not been well studied.   
 While the specific renal diseases cited above are causative in some cats with CKD, in contrast 
to dogs and people with CKD, the vast majority of cats with CKD lack an apparent initiating 
cause.
50
  It is unlikely that the tubulointerstitial changes observed in cats with CKD simply 
represent the final common pathway of renal destruction
41
 even when observed in IRIS CKD 
stage 4, since these same lesions are observed in early feline CKD,
50,146
 albeit to a lesser extent. 
The presence of similar tubulointerstitial changes in early and advanced stages of feline CKD is 
consistent with the proposal that one or more primary tubulointerstitial insults are critical 
initiation factors in feline CKD.  While it is tempting to speculate that a single, previously 
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unknown primary disease such as an infectious or genetic
18
 etiology will be uncovered, it seems 
more likely that a combination of intrinsic (animal) factors, environmental factors and/or 
repeated intermittent acute kidney insults (AKI) act in concert as initiating or causative factors. 
 
Aging as an Initiation Factor 
An abundance of evidence supports a link, perhaps causal, between aging and feline CKD,  
including: 
• Increasing prevalence of CKD in older cats
10,121
 
141
 
163
  
• Increased prevalence of sclerotic glomeruli in kidneys from geriatric cats
146
 
• Shortened telomere length in aged cats with CKD
165
 
• Enhanced susceptibility of geriatric people to renal insults
199
 
200
 
176
 
• Alterations in antioxidant defenses in feline CKD
114,123,213
 
• Increased prevalence of comorbid conditions in older cats, particularly those known to 
affect the kidneys, such as hyperthyroidism, systemic hypertension, dental disease, and 
inflammatory bowel disease 
 Since the prevalence of CKD is greatest in geriatric populations in all species, the majority of 
cats have an idiopathic disease, and at least one other group of felids (captive cheetahs) have a 
similarly high prevalence of CKD,
20,152,153
  it is tempting to suggest that CKD is part of the aging 
process in domesticated cats in particular, or felids in general. However, this high prevalence in 
aged cats does not, by itself, establish a role for aging in the initiation of feline CKD.  A portion 
of this increase in prevalence in geriatric cats reflects persistence of CKD rather than a rise in 
incidence with advancing age, as CKD is not readily reversible and, once acquired, it rarely 
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resolves. The rising prevalence of CKD in people as they age is at least partly due to the 
accumulation of chronic renal diseases.
214
   In a species in which CKD progresses slowly or is the 
cumulative result of multiple intermittent acute insults over time, such as cats,
51,76
 a greater 
prevalence of CKD would be expected in older animals.   
 Despite intense study, whether an aged kidney is prone to the development of CKD, has 
heightened susceptibility to acute insults, or whether aging is itself a primary renal disease, 
remain unproven hypotheses. When physiological, morphometric, and imaging techniques 
were used to mathematically model glomerular filtration rate (GFR) and its determinants in a 
group of older (≥ 55 years) compared to younger (≤ 45 years) human living kidney donors,
190
 
there was an observable decline in GFR in older donors attributable to glomerulopenia.  Clearly, 
there are similar age-associated changes in feline kidneys.  For example,  the prevalence of 
globally sclerotic glomeruli is greater in older (> 7 years of age) compared to younger (< 5 years 
of age) cats.
146
  Shortening of telomere length with aging is a genetic factor that could be 
associated with this glomerular and nephron senescence.   When telomere length was assessed 
in kidney, liver and skin from 12 cats with naturally occurring CKD, 12 young normal cats, and 6 
older normal cats, there was evidence of shortened telomeres and increased cellular 
senescence in renal epithelium from cats with CKD.
165
  However, in this study, age alone did not 
appear to result in significant telomere shortening as shortened telomeres were not present in 
the kidneys, skin, or liver of older normal cats or in the skin or liver from cats with CKD. 
 As further evidence that CKD is not an inevitable consequence of aging in people and cats, 
one-third of elderly human beings have a normal GFR,
214
  and 19-65% of geriatric cats exhibit 
no clinical evidence of CKD.
10,121,141
 Therefore, aging by itself does not initiate CKD.  It is 
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plausible, however, that age-associated changes enhance susceptibility to the development of 
CKD. Aging changes in human kidneys seem to predispose them to injury from a variety of 
insults, including ischemia, nephrotoxicity, and inflammation
199,200
 and renal function is less 
likely to recover following kidney damage in aged human beings.
176
  Renoprotective systems, 
such as antioxidant defenses, may be affected in aged cats with CKD.
114,123,213
  However, 
antioxidant defense mechanisms are not exhausted in aged cats, even those with IRIS stage 4 
CKD.
123
  There are other well-known effects of aging on the kidney. These include mitochondrial 
dysfunction, heightened intra-renal inflammatory response, and increased cellular 
senescence.
164
 Further, there is an age-associated reduction in Klotho gene expression in 
people,
215
 which is believed to have an adverse effect on vascular regulation and endothelial 
cell health.
139,142
 Any similar, age-associated compromise of protective or reparative systems in 
cats would be expected to play a role in the response to other insults.   
 Extra-renal diseases that are more common in aged cats may adversely impact their kidneys.  
Examples include hyperthyroidism, dental disease, systemic hypertension, and inflammatory 
bowel disease.  In other species, hyperthyroidism increases renal blood flow and GFR and 
causes hyperplasia and hypertrophy of tubular epithelium,
195
 and there is indirect 
evidence
1,62,91,206,207
 that the same kinds of changes occur in the kidneys of hyperthyroid cats.  
Hyperthyroidism contributes to renal injury in certain settings in rats,
151
 but whether 
hyperthyroidism could cause tubulointerstitial disease in cats remains uncertain.   While 
hyperthyroidism enhances feline renal blood flow,
2
 the consequences of this hyperperfusion 
and the direct effects of excess thyroid hormone on feline tubular cells are not well understood.  
Hyperthyroidism might be expected to directly, or indirectly as a result of an increase in GFR,
2
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result in disordered nephron enlargement, including podocyte hypertrophy.
122
   Podocyte 
hypertrophy, along with glomerular enlargement, would be expected to result in podocyte loss 
and focal segmental glomerulosclerosis.  However, convincing evidence is lacking, as most cats 
with CKD do not have overt hyperthyroidism and the glomerulosclerosis observed in cats with 
CKD is mild and non-obliterative.
50
 
 In cats, an association between dental disease and CKD has been suggested. 
73,92
  In people, 
periodontal disease is a risk factor for the development of CKD
79
 and is associated with 
declining renal function and mortality,
55
 perhaps through enhancement of the systemic 
inflammatory burden.
79,172
  Worsening of oral health and periodontal disease have been shown 
to occur as CKD advances in dogs
87
 and in people,
189
 indicating that this is a complex, and 
perhaps bidirectional,
80,197
 relationship. 
 A role for systemic hypertension
15,75,183
 and intraglomerular hypertension
29,36,38,42,44,97
 in the 
initiation and progression of CKD has been proposed in other species.  While systemic 
hypertension is common in cats with CKD,
68,108,186
 it is usually not clear if the high pressures 
precede, or are coincident with, the initiation of CKD.  If present, increases in blood pressure 
with advancing age could play a role in the initiation of feline CKD.  Although not all studies 
have found an age-associated change in blood pressure in cats,
180
 a longitudinal study 
demonstrated that blood pressure increases with age in cats, whether they have CKD or are 
otherwise healthy
16
 and a second study demonstrated a correlation between age and feline 
blood pressure.
19
  However, the importance of the kidneys in the regulation of blood pressure is 
well known in other species and a more plausible explanation is that the CKD precedes the 
hypertension, which then establishes a vicious cycle, contributing to further renal damage as a 
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progression factor and so on.  Given the prevalence of CKD and the difficulty of establishing a 
diagnosis of the early stages of feline CKD, the presence of subclinical CKD which compromises 
the ability of the kidneys to regulate blood pressure would be expected to occur in a population 
of geriatric cats.  
 People with inflammatory bowel disease may exhibit tubular dysfunction
82
 and 
tubulointerstitial nephritis.
5,140
  Feline inflammatory bowel disease,
110,193,198
 particularly 
longstanding, might be expected to enhance the systemic inflammatory burden and permit 
access to the kidney for molecules normally retained in the intestinal tract.  Either of these 
changes could contribute to renal injury.  However, the nephropathy in people with 
inflammatory bowel disease is typically mild and it is difficult to determine if the renal changes 
are due to the inflammatory disease, drug therapy, or both.
5,160
  Whether there is a relation 
between inflammatory gastrointestinal disease and feline CKD is an interesting, 
unsubstantiated hypothesis.
201
   
   
 
 
Ischemia and Other Acute Kidney Insults (AKI) as Initiation Factors 
It has been suggested that renal tubular hypoxia is an important factor in the development and 
progression of CKD in people.
179
 In kidneys, renal cortical perfusion is much higher than 
medullary.  As a result, within normal kidneys, the tissue pO2 is approximately 45 mmHg in the 
cortex but falls progressively to ~10 mmHg in the medulla.
159
  The S3 portion of the proximal 
tubule and the medullary thick ascending limb within the corticomedullary junction are 
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simultaneously metabolically active and comparatively hypoxic, even in normal kidneys and 
thus these segments are quite susceptible to hypoxic injury.    A single bout of renal ischemia 
induces chronic structural changes within the feline kidney that mirror findings in feline CKD, 
specifically tubular atrophy, interstitial fibrosis and mononuclear inflammation.
175
    
In this study,
175
  the renal artery and vein of one kidney were clamped for 60 minutes, and renal 
changes attributed to this ischemic event were followed over time.  Severe lesions of AKI, 
including tubular epithelial coagulative necrosis and epithelial regeneration, predominantly 
affected the straight portion of the proximal tubules and thick ascending limb of the loop of 
Henle within the corticomedullary junction.    As expected, the S3 portion of the proximal 
tubules were affected by this hypoxic insult.
17
  These early changes were followed by chronic 
changes of interstitial fibrosis, tubular atrophy, and mononuclear cell inflammation both 
diffusely within the corticomedullary junction and as linear foci within the cortex, similar to 
those seen in cats with naturally occurring CKD (Fig 12).  Increased smooth muscle actin (SMA) 
expression, indicative of myofibroblast activation in profibrotic conditions, is present in kidneys 
from cats with both experimental
175 
and naturally occurring CKD.
174,211
 This study provides 
evidence that AKI, specifically ischemic AKI, initiates changes that mimic CKD in cats,
175
 
consistent with the suggestion that maladaptive repair mechanisms following an AKI can lead to 
CKD.
72
   
 Following acute damage to the kidney, remnant tubular epithelial cells dedifferentiate, 
proliferate, and replace lost epithelial cells to restore tubular structure.
23
  An intact basement 
membrane plays a crucial role in this regenerative process, providing a scaffold along which 
regenerating epithelial cells can spread and migrate.
130
   Ischemic, in contrast to toxic, insults 
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may be associated with disruption of the tubular basement membrane (ischemic tubulorrhexis).  
Tubulorrhexis occurs in cats following experimentally induced renal ischemia (Fig. 13). 
175
   
Following tubular rupture, free lipid in the interstitium, presumably derived from tubular 
epithelial cells, is associated with chronic granulomatous inflammation.  Similarly, foci of free 
lipid and granulomatous inflammation are commonly observed in cats with spontaneous CKD 
(Fig. 6), which may similarly represent foci of past ischemic tubulorrhexis.  In a recent study, 
most IRIS CKD stage 2 cats and all stage 4 cats had interstitial lipid and associated 
inflammation
146
 as well as tubular degeneration, interstitial fibrosis, and glomerular 
obsolescence. The changes were significantly more severe in advanced stages,
146
  and could 
represent the cumulative effects of multiple ischemic insults. 
 Inflammation plays a major role in the pathophysiology of ischemic AKI in other species. 
24
  
Endothelial cells, particularly within the outer medulla, are activated after ischemia, resulting in 
upregulation of leukocyte adhesion molecules.  Endothelial injury also results in cell swelling 
and decreased vessel patency, further contributing to regional ischemia.  In addition, proximal 
tubular epithelial cells contribute to the inflammatory response through their generation of 
pro-inflammatory and chemotactic cytokines such as TNF-α, monocyte chemoattractant 
protein-1 (MCP-1), TGF-β, and IL-6. 
24
   A reduction in the density of the microvasculature 
following an ischemic AKI has been hypothesized to play a role in the development and 
progression of CKD in other species.
11
  Chronic hypoxia induced by loss of peritubular capillaries 
may stimulate tubulointerstitial fibrosis through upregulation of profibrotic factors such as TGF-
β and extracellular matrix genes.  As inflammation worsens and interstitial fibrosis separates 
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tubules from peritubular capillaries (Figs. 14, 15), resultant tubular hypoxia would be expected 
to increase fibrosis, creating a maladaptive positive feedback loop.   
 
 
Environmental Factors as Initiators of Feline CKD 
 Besides phosphorus, other dietary factors could play a role in the initiation of feline CKD as 
dietary modification has a beneficial effect, apparently to slow the rate of renal damage, in cats 
with IRIS CKD stages 2 and 3.
171
  While important as a progression factor, whether dietary 
phosphorus intake plays a role in the initiation of feline CKD remains unknown. Similarly, there 
is evidence for an effect of high dietary sodium intake as a progression factor in established 
feline CKD,
117
 but not as an initiation factor in healthy, aged cats.
167
 Other husbandry factors, 
such as ad lib feeding of high protein diets, could play a role in the initiation or progression of 
feline CKD as has been hypothesized in people 
29
 but evidence that dietary protein intake plays 
a role is lacking in this species.
76
 
 Certainly unintended consequences of food additives have been shown to cause severe AKI 
in cats.
30,31,212
  Indeed, a relationship between dietary additives, such as ethoxyquin,
94,155
 and 
renal injury in cats has been hypothesized but never established.  Potential risks to the health of 
people from exposure to genetically modified (GM) plants have been discussed,
7,21,184
 but the 
authors are not aware of any studies of their impact on the kidney of any species.  While 
controversial, there is some evidence that exposure to glyphosate, a herbicide commonly used 
in GM agriculture, may have toxic renal effects at levels found in the environment and in 
food
148,149
 and that exposure to environmental glyphosate can contribute to the development 
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of CKD in people.
105
  The authors are not aware of any studies in cats that address either the 
safety of ingestion of GM plants or environmental exposure to glyphosate.    In human health, 
this topic remains politicized, commercialized, speculative, and controversial.
65
  
  The increased prevalence of feline CKD in recent decades might, in part, be attributable 
to alterations in other environmental factors, such as changes in feeding, housing or vaccination 
patterns. Routine vaccination has been hypothesized to be an initiating factor of 
tubulointerstitial disease and CKD in cats.   Vaccine viruses typically have been grown in the 
Crandell Rees feline kidney (CRFK) cell line and cats inoculated with CRFK cell lysates or with 
vaccines grown on CRFK cells develop antibodies against CRFK cells and these antibodies react 
with feline renal cell extracts.
128
 Putative target antigens have been identified
205
  and 
lymphocytic-plasmacytic interstitial inflammation has been observed in some cats chronically 
inoculated with CRFK cell lysates.
127
  However, not all of the cats that were hyperimmunized 
with CRFK cell lysates developed interstitial nephritis and mild interstitial inflammation was 
present in some cats before inoculation.  In an epidemiological study of feline CKD, the 
development of CKD was linked to vaccination frequency. 
73
 Speculatively, the inflammatory 
response to rupture of tubular cells, whether from apoptosis, senescence, toxicity, or ischemia, 
might be more severe in vaccinated cats.  While vaccination could be an initiation (or 
progression) factor for CKD in cats, further studies are needed. 
 In cats, stress has been linked to diseases of the skin
4
 as well as the gastrointestinal,
181
 
respiratory
191
 and urinary
47,48,202
 systems. Confinement, co-feeding, litterbox sharing, and co-
habitation with other animals (e.g., cats, dogs, people) variously have been suggested as causes 
of stress for domesticated cats.  The loss of predictability and control of its environment might 
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lead to chronic over-activation of a cat’s sympathetic nervous system and hypothalamic-
pituitary-adrenal axis.
4,202
  The prevalence of CKD in captive, but not free-ranging, 
cheetahs
20,152,153
 could in part reflect a similar effect of environmental stress.   
 
Potential Causes of Renal Hypoxia in Cats 
 The morphologic sequelae of an experimental ischemic insult
175
 mirrors the typical 
appearance of CKD in cats, suggesting renal hypoxia could be an initiation factor in cats.  This is 
consistent with the view in other species that AKI can serve as an initiator of CKD.  It is thought-
provoking to speculate as to potential causes of renal hypoxia in cats.  A variety of host factors 
and conditions could contribute to acute or chronic bouts of renal hypoxia in aging cats and 
these include (Fig. 16): 
• Stress and over-activation of the sympathetic nervous system 
• Aging 
• Tubular hypermetabolism causing relative ischemia (high tubular metabolic activity 
exceeding delivery of oxygen) 
• Anemia   
• Transient insults to renal hemodynamics, such as episodes of systemic hypotension, 
sympathetic nervous system overactivity, or activation of the renin-angiotensin-
aldosterone system 
• Subclinical exposure to compounds with effects on the renal vasculature or tubular 
epithelium (e.g., nonsteroidal anti-inflammatory drugs or melamine) 
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 Environmental stress associated with chronic over-activation of the sympathetic nervous 
system could contribute to renal injury in cats by several mechanisms.  Since renal sympathetic 
stimulation constricts the afferent arterioles of nephrons in other species
54,81
 and reduces the 
flow within the descending vasa recta by inducing contraction of pericytes that encircle these 
vessels,
59
 increased sympathetic system activity would be expected to produce reductions in 
renal blood flow, particularly in the medulla.  Concurrent dehydration and activation of the 
sympathetic nervous and renin-angiotensin-aldosterone systems synergistically compromise 
the renal microcirculation in rats
119
 due in part to pericyte-mediated constriction of the vasa 
recta capillaries (induced by angiotensin II and catecholamines),
59
 but also due to arteriolar 
constriction mediated by angiotensin II
39
 and aldosterone.
124
  The presence of other 
vasoconstrictors, such as thromboxane A2 or endothelin,
49
 could augment this vasoconstriction, 
leading to segmental tubular hypoxia. This may be relevant to the initiation (and progression) of 
CKD in cats, since dehydration
162
 and stress are common findings in aged cats, particularly 
those with CKD. Other stress-associated changes could have an impact on renal perfusion. For 
example, stress-associated activation of the sympathetic nervous system contributes to blood 
pressure variability in people.
89
  Changes in feline blood pressure associated with the 
environmental stress of a simulated visit to a veterinary clinic included transient bouts of 
marked hypertension and hypotension.
14
   Although a role for primary hypertension as an 
initiator of CKD in cats remains tenuous, cats were shown to have particularly labile systemic 
arterial blood pressure
14,45,166,192
  with the observed changes in blood pressure patterns 
persisting as long as several months after a psychosocial stress regimen in cats.  
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 The study linking hypoxia to chronic tubulointerstitial changes in feline kidneys
175
 was 
conducted in young adult cats.  A number of the changes associated with aging discussed 
above, including mitochondrial dysfunction, cellular senescence, increased oxidative stress, and 
reduction in Klotho gene expression, would be expected to either enhance the likelihood or 
worsen the consequences of hypoxia in the kidneys of aging cats. Aging aggravates the 
magnitude of renal injury from ischemic episodes in rats.
210
  If aging similarly predisposes feline 
kidneys to hypoxic injury, particularly to normotensive renal ischemia as hypothesized to be the 
case in people,
200
 then renal hypoxia could be an important initiator of CKD in cats.   
 In certain settings, such as the glomerulopenia of aging, the metabolic demands on tubular 
cells are increased.  This so-called tubular hypermetabolism is believed to produce cellular 
injury by a variety of mechanisms, including oxygen free radical generation. 
96,178
  The 
restriction of dietary intake of some nutrients, including phosphorus,
96
  diminishes the 
metabolic activity of tubular cells and lessens renal damage in rats.
96
  Plasma phosphorus 
concentration at the time of diagnosis of CKD is positively associated with progression of IRIS 
CKD stage 3 in cats
51
 and efforts to control hyperphosphatemia are renoprotective  in both the 
remnant kidney model in cats
169
 and in spontaneous feline CKD.
69
  In the remnant kidney model 
of feline CKD, phosphorus overload induces changes similar to those observed in spontaneous 
feline CKD, specifically tubulointerstitial fibrosis, mononuclear infiltrates, and 
nephrocalcinosis.
170
  The mechanisms contributing to these changes are poorly understood, but 
tubular hypermetabolism and hypoxia from relative tubular ischemia could be factors in this 
injury.  Furthermore, if a “normal” aspect of aging in cats is loss of nephrons,
129
 then the 
resultant interstitial inflammation, edema, and/or fibrosis could expand the interstitial space, 
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limiting oxygen delivery to remaining nephrons. If senescent nephrons are prone to the 
development of glomerulosclerosis, then the post-glomerular segments of affected nephrons 
would be expected to become hypoxic.  This injury could be exacerbated by transient, 
subclinical exposure to nephrotoxins (e.g., melamine or nephrotoxic antibiotics) or by 
inflammation induced by feline vaccines. 
128
  
 In established feline CKD, anemia that is primarily attributable to decreased erythropoietin 
production develops in 30-65% of affected cats.
52
  Consistent with the hypothesis that feline 
kidneys are susceptible to hypoxic injury, the presence of this low red cell mass is a predictor of 
progression of CKD in cats.  Age-associated changes in red cell mass are incompletely 
characterized in cats but anemia is a common problem in elderly human beings
147
 and if 
present, would be expected to predispose aging cats to renal hypoxia.  In cats with anemia, 
other systemic disturbances, such as dehydration or systemic hypotension, would be expected 
to synergistically affect renal tubular epithelium. This would be especially true for certain 
medullary segments of the nephron (S3 and medullary thick ascending limb), as these tubular 
segments are metabolically active but reside in a comparatively hypoxic region, even in normal 
kidneys.
159
 
 The control of the renal vasculature is complex.  As noted above, acute hypoxic insults to the 
kidneys could result from imbalances between intrarenal vasodilatory and vasoconstrictive 
factors, as is suspected to be the case in cats with nephrotoxicosis from nonsteroidal anti-
inflammatory drugs (NSAIDs).
100
   Inhibition of cyclooxygenase enzymes within the kidney is 
thought to decrease the production of vasodilatory prostanoids which normally help to 
maintain renal blood flow in the face of vasoconstrictors.
115
  In particular, both cortical and 
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medullary blood flow are reduced by the administration of NSAIDs,
88
 and NSAID-induced 
nephropathy is characterized by papillary necrosis and interstitial nephritis.   Acute tubular 
injury from NSAID-nephropathy is similar to that seen in cats with an experimental ischemic 
insult of the kidney (Figs. 17, 18), involving the S3 portion of the proximal tubules.
17
  In 
domesticated cats, factors that alter the control of renal hemodynamics, such as NSAID 
administration, are often coupled with stressful events, such as painful stimuli or 
hospitalization, which activate the sympathetic nervous system.  Affected cats may be 
dehydrated or hypotensive, which would increase systemic and intrarenal generation of 
angiotensin II with its effects to constrict the efferent arteriole and vasa recta pericytes.  Such 
combinations would be expected to result in medullary hypoxia and tubular injury.  As there are 
no clinical indices for the direct detection of medullary injury, the importance of these types of 
interactions in the initiation (and progression) of feline CKD are speculative but deserve further 
attention. 
Progression Factors in Feline CKD 
Based on laboratory studies in rats
28
 and dogs,
40
 and clinical studies in people
60,98
 and dogs,
101-
103
 it has been assumed that feline CKD is an inherently progressive disease.  However, it is 
difficult to demonstrate progressive deterioration of renal function (GFR) in laboratory models 
of feline CKD.
76,169
 Similarly, analysis of serial measurements of serum creatinine concentration 
demonstrate that spontaneous feline CKD is often slowly progressive or non-progressive,
51
 
although this is highly variable. While some cats with spontaneous CKD progress more rapidly, 
these cases are more difficult to study. Despite the absence of specific therapeutic 
interventions, a large proportion of cats with CKD (53%) did not exhibit progressive increases in 
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serum creatinine concentration in 1 year. 
51
  Upon necropsy evaluation, cats without readily 
identifiable causes for their CKD tend to be older, suggesting that idiopathic CKD is often a 
slowly progressive or non-progressive disease. 
50
 
 Beyond persistence of an initiating primary renal disease, a number of additional factors 
have been implicated in the progressive decrements of GFR observed in CKD in a variety of 
species.
41,113
  In these other species, progression factors (Fig. 11) operate independently of the 
primary disease, are activated by adaptive changes in the animal or through secondary effects 
of reduced renal function, and are held to be responsible for what is commonly termed 
inherent or intrinsic progression of CKD.
41
  Several factors have been associated with 
progression of feline CKD: 
• Phosphorus intake 
• Proteinuria 
• Anemia 
• Systemic hypertension 
• Intraglomerular hypertension 
• Activation of the renin-angiotensin-aldosterone system 
• Sodium intake 
• Tubular hypoxia 
 Progression or mortality in cats with CKD are associated with some of the implicated factors 
including disorders of phosphorus homeostasis,
51,67,84,85
 proteinuria
51,70,187,188
 and anemia.
51
   In 
cats in IRIS stages 2 and 3, a number of dietary manipulations including phosphorus restriction, 
reduced the incidence of uremic episodes and renal-related deaths.
171
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  As noted previously, systemic hypertension is observed in many cats with CKD,
16,68,186
 and is 
associated with the development of target-organ injury,
132,138,144,173,182
 
143
 
32
 proteinuria,
108,188
 
and azotemia
107
 in cats. Because the risk of high blood pressure to target organs in cats has 
been recognized for more than 2 decades,
132
 placebo-controlled clinical trials of the effects of 
hypertension on progression of feline CKD are difficult to design. As a consequence, the 
importance of hypertension as a progression (or initiation) factor in feline CKD is uncertain.   
 Intrarenal hemodynamic changes that may contribute to progression have been studied in 
cats.  Based on micropuncture studies in a model of feline CKD, glomerular capillary 
hypertension and glomerular hyperfiltration develop as adaptive changes in response to 
reductions in renal function or nephron loss.
35,39
  These hemodynamic changes are arguably a 
maladaptation
34,97
 that contributes to proteinuria in cats.
35
  Studies in uninephrectomized aged 
dogs,
77
 and in older human kidney donors
190
 demonstrate that aged kidneys exhibit adaptive 
hyperfiltration and renocortical hypertrophy. Thus, if nephron loss occurs as a general 
phenomenon in aging cats or as a consequence of other insults, it is likely that these same 
maladaptive, intraglomerular changes would occur in remnant feline nephrons and if so, these 
alterations could contribute to future decrements in renal function.  In other species, there is 
evidence that glomerular hypertension and proteinuria lead to damage to the kidneys through 
nephron destruction.  In particular, inhibitors of the renin-angiotensin system, which would be 
expected to reduce intraglomerular pressure and proteinuria, seem to be renoprotective in 
dogs
42,46,83,90
 and people.
104,196
  Micropuncture studies demonstrate that inhibition of 
angiotensin converting enzyme lowers intraglomerular pressure in remnant feline nephrons
39
 
and this approach reduces proteinuria in cats with spontaneous CKD.
116
  However, it was not 
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possible to demonstrate an overall beneficial effect on survival or renal function in the latter 
study.
116
  While increased plasma aldosterone concentrations have been documented in cats 
with CKD, plasma renin activity is usually either normal or low.
106,109
  Unlike dogs, there was no 
relation between intra-renal expression of renin and angiotensin II and interstitial fibrosis in 
cats.
150
 Although secondary hyperaldosteronism remains of interest, it may be that the 
systemic and intrarenal renin-angiotensin systems and changes in glomerular blood pressure 
are less important in feline CKD than in the CKD of other species. Interestingly, high sodium 
diets have been associated with enhanced rate of progression of CKD
117
 but in long-term trials 
(2 years) had no adverse effects on blood pressure
56
 or renal function
167
 in normal cats. 
 In cats with reduced renal mass there is marked and preferential dilation of the afferent 
arterioles,
44
  which is responsible for the glomerular hypertension and hyperfiltration observed 
in remnant nephrons. Given the large increase in tubular oxygen demands associated with 
processing this large filtered load per nephron,
44
 it has been suggested that intermittent 
tubular hypoxia and oxidative injury may be present in affected people.
178
  Evidence suggests 
that antioxidants delay progression in people with pre-dialysis CKD
111
 and in a laboratory model 
of CKD in dogs.
33
  There is evidence of altered antioxidant status in cats with CKD
114,123
 and of a 
beneficial systemic effect of antioxidants
213
 which would support the hypothesis that relative, 
or absolute, hypoxia plays a role in the progression of feline CKD 
Interstitial Fibrosis: Friend or Foe 
 Interstitial fibrosis is present in early feline CKD and becomes more severe with advancing 
disease,
50,146
  suggesting that renal fibrosis is important in the progression of feline CKD.  
However, this fibrosis is generally viewed as occurring secondary to injury, not as a primary 
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event.  Many of the factors implicated in progression of CKD in cats, including proteinuria, 
systemic hypertension, chronic inflammation, anemia, hypoxia, aging, and hyperphosphatemia, 
are viewed as promoters of fibrosis.
130
  In other species, renal injury is marked by elevated 
levels of the phosphaturic hormone, fibroblast growth factor-23 (FGF-23) and a deficiency of its 
co-receptor, Klotho.
95,158
  These changes promote renal fibrosis.
131
  Elevated FGF-23 levels 
predict the development of azotemia in geriatric cats 
74
 and the likelihood of progression and 
mortality in cats with azotemic CKD.
84
  It seems likely that this axis contributes to the 
progression of renal injury and fibrosis in established CKD in cats but it is unclear whether or 
not this axis plays a role in the initiation of renal injury in this species.  
 The characterization and origin of the cells that produce interstitial fibrosis has been 
extensively studied.  These cells, referred to as myofibroblasts based on SMA expression and 
fibroblastic morphology, are derived primarily from activation of resident interstitial fibroblasts.  
Other plausible precursors of myofibroblasts include circulating bone marrow-derived cells or, 
rarely, transdifferentiation from epithelial or endothelial cells.
137
  Epithelial-mesenchymal 
transdifferentiation is a proposed mechanism whereby tubular epithelial cells transform into 
mesenchymal cells, migrate into the interstitium, and produce collagen.  While this transition is 
found in the context of embryonic development and in adult cancer cells associated with tumor 
invasion and metastasis, there is conflicting data concerning its existence in vivo, and if present 
at all, the contribution of this transdifferentiation to fibrosis is almost certainly less significant 
than previously thought.
137
    In the normal kidney, interstitial fibroblasts play a crucial role in 
homeostasis of the extracellular matrix through the production of matrix and matrix-degrading 
proteases.
130
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 Regardless of the origin of myofibroblasts in the feline kidney, increased interstitial 
connective tissue certainly could contribute to renal injury. In the kidneys, residual peritubular 
fibrosis can disrupt the close association between interstitial capillaries and tubules, leading to 
tubular ischemia and tubular atrophy (Figs. 14, 15). Thus fibrosis as a cause of ischemia could 
contribute to progression of feline CKD.  As noted above, if nephron senescence is a normal 
part of aging in cats,
129
 then the resultant fibrosis could act as an initiator of progressive CKD by 
contributing to regional tubular hypoxia. However, the presumption that renal fibrosis is 
universally detrimental is likely an oversimplification.  Following an acute insult, for example, 
the course of renal fibrosis can be divided into multiple phases, with varying implications for 
intervention.
137
  In particular, early after renal damage, fibrosis might play a beneficial role in 
repair by providing structural integrity to injured tubules during regeneration.  Defining the role 
of renal fibrosis in inducing hypoxic renal injury and/or progression of CKD in cats requires 
further study. 
 
Future directions 
 Many, perhaps most, aged cats exhibit clinical or pathological evidence of CKD. The 
pathological changes observed in the kidneys of cats with CKD suggest that nephron loss, 
inflammation, and fibrosis are important features of this disease.  A number of factors have 
been implicated in progression of established CKD in cats, including hyperphosphatemia, 
proteinuria, anemia, systemic hypertension, aging, and tissue hypoxia.  Unfortunately, except 
for hypoxia and aging, there is a paucity of direct evidence to suggest that these progression 
factors play a role as an initiator of CKD in this species.  Instead, the primary cause(s) of this 
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disease, the initiator(s), remain unknown or hypothetical (e.g., aging and renal hypoxia).  
Solving this mystery will require studies that define the cellular and molecular events that 
contribute to tubular cell death, intrarenal inflammation and interstitial fibrosis in cats 
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Table 1. Staging of feline chronic kidney disease using the criteria of the International Renal  
 
Interest Society (IRIS CKD Stages)
71
 
 
 IRIS CKD Stage 
 Stage 1 Stage 2 Stage 3 Stage 4 
Serum creatinine (mg/dL) 
                               (µmol/L) 
<1.6 
 
<140 
1.6-2.8 
 
140-250 
2.9-5.0 
 
251-440 
>5.0 
 
>440 
 
Median survival   (days)
26
 
 
unknown 
 
1151 
 
679 
 
35 
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Figure Legends 
Figures 1 -2.  Primary glomerular disease and chronic kidney disease (CKD), kidney, 12 year old 
cat.   
Figure 1.  There is segmental interstitial fibrosis, interstitial lipid with inflammation (asterisks), 
and glomerular obsolescence (arrow).  Inset:  The enlarged glomerulus exhibits endocapillary 
hypercellularity suggestive of membranoproliferative glomerulonephritis (MPGN).  Periodic 
acid-Schiff-hematoxylin (PASH).   
 
Figure 2.  Ultrastructural confirmation of MPGN with identification of subendothelial electron 
dense deposits (long arrow) in areas of mesangial interposition.  Evidence of podocyte injury 
include foot process effacement (arrowheads) and podocyte protein resorption droplets (short 
arrow).  Bar = 2 microns. Transmission electron microscopy. 
 
Figures 3-6.  CKD, kidney, geriatric cat.   
Figure 3. The capsular surface is granular and pitted. 
 
Figure 4.  Multifocal to segmental distribution of lesions in the cortex.  Clusters of preserved 
proximal tubules (P) are present between areas of fibrosis.  Glomerulus with global sclerosis 
(arrow). Masson’s trichrome. 
 
Figure 5.  Cluster of atrophic tubules separated by interstitial fibrosis.  Tubules are decreased in 
diameter, have markedly thickened and wrinkled tubular basement membranes, and are lined 
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by variably sized vacuolated epithelial cells. A distal tubule (D) contains a hyaline cast.  Mildly 
dilated proximal tubule (P).  PASH. 
 
Figure 6.  Atrophic tubules with basement membrane attenuation (arrowhead) and interstitial 
lipid with granulomatous inflammation (arrow).  PASH. 
 
Figure 7.  Normal kidney, young adult cat.  The basement membrane of Bowman’s capsule is 
thin and uniform (long arrow) and the parietal epithelial cells are flattened (short arrow).  
Vascular pole (arrowhead). Proximal tubule (P).  Distal tubule (D).  PASH. 
 
Figures 8-10.  Chronic kidney disease (CKD), kidney, geriatric cat.   
Figure 8. The glomerulus is enlarged and there is irregular thickening of Bowman’s capsule (long 
arrow).  There is hypertrophy and hyperplasia of the parietal epithelium (short arrows) and mild 
mesangial matrix expansion (mild glomerulosclerosis). Vascular pole (arrowhead). Proximal 
tubule (P).  Distal tubule (D).  PASH. 
 
Figure 9.  The glomerulus exhibits marked wrinkling of the glomerular basement membrane 
with capillary collapse and sclerosis (ischemic global glomerulosclerosis).  Fibrous connective 
tissue is present within urinary space (arrow).  Vascular pole (arrowhead).  Proximal tubule (P).  
PASH. 
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Figure 10.  Obsolescent glomerulus with loss of glomerular capsule and infiltration with 
mononuclear inflammatory cells.  PASH.  
 
Figure 11. Proposed pathogenetic mechanisms involved in the initiation and progression of 
chronic kidney disease (CKD) in cats.  In this widely accepted model of the course of CKD, one or 
more factors initiate the renal injury (Initiation), leading to changes in renal structure and 
function (Consequences).  If the disease progresses unabated, disruption of homeostasis 
coupled with maladaptive renal responses further contribute to renal damage and nephron loss 
(Sequelae).   These consequences and sequelae operate synergistically as a positive feedback 
loop which, absent therapeutic intervention, eventually leads to end-stage renal failure.  
Glomerular filtration rate (GFR).  See text for further explanation.  
 
 
Figure 12.   Kidney, cortex, young adult cat, 70 days following single 60-minute episode of 
experimental unilateral renal ischemia.  Segmental foci of interstitial fibrosis, tubular atrophy, 
and mild interstitial inflammation with relative preservation of groups of proximal convoluted 
tubules (P).  Masson’s trichrome. 
 
Figure 13.  Kidney, corticomedullary junction, young adult cat, 42 days following single 60-
minute episode of experimental unilateral renal ischemia.  Disruption of the tubular basement 
membrane (tubulorrhexis, arrow) with release of lipid (arrowhead) and resultant 
granulomatous inflammation.  PASH. Reprinted with permission; ref
175
.  
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Figure 14.  Normal renal cortex, dog.  The tubular basement membrane is thin and uniform 
(arrow).  Tubules are separated by minimal interstitial tissue (arrowheads) and capillaries (C).  
Bar = 10 microns.  Transmission electron microscopy (TEM). 
 
Figure 15.  Renal cortical fibrosis, dog.  The tubule is reduced in size with severe thickening and 
wrinkling of the tubular basement membrane (tubular atrophy, long arrow).  The interstitium is 
markedly widened by fibroblasts (short arrows) within an abundant collagenous stroma.  
Collagen fibers in cross (asterisks) and longitudinal (arrowheads) section.  Bar = 10 microns. 
TEM. 
 
Figure 16. Tubular hypoxia and chronic kidney disease.  Tubular hypoxia acting alone or in 
concert with other factors may cause tubular epithelial cell injury, interstitial inflammation, and 
eventual fibrosis and tubular atrophy (CKD).  Potential mechanisms of tubular hypoxia include 
extrarenal factors (hypotension, anemia) and intrarenal factors (arteriolar constriction, 
glomerulosclerosis, pericyte contraction) resulting in decreased blood flow (or oxygenation) 
through peritubular capillaries and vasa recta, resulting in transient or continued tubular injury 
from hypoxia.  Disruption of the normal close association of capillaries and tubules by an 
expanded interstitium perpetuates tubular hypoxia. 
 
Figure 17.  Acute ibuprofen toxicosis, kidney, corticomedullary junction, young adult cat.  There 
is acute tubular injury, characterized by coagulative necrosis (long arrow) and marked epithelial 
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vacuolization (short arrow).  Note leukocytes within vasa recta (asterisk), indicative of acute 
ischemia.   Hematoxylin and eosin (HE). 
 
Figure 18.  Kidney, corticomedullary junction, young adult cat, 3 days following single 60 minute 
episode of unilateral renal ischemia. There is acute tubular injury, characterized by coagulative 
necrosis (long arrow) and epithelial vacuolization (short arrow).  Leukocytes within vasa recta 
(asterisk).  HE. 
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